Health & Fitness
Health and Fitness
Health and Fitness
Mon, October 22, 2012Sun, October 21, 2012Sat, October 20, 2012Fri, October 19, 2012Thu, October 18, 2012Wed, October 17, 2012Tue, October 16, 2012Mon, October 15, 2012Sun, October 14, 2012Fri, October 12, 2012Thu, October 11, 2012Wed, October 10, 2012Tue, October 9, 2012Mon, October 8, 2012Sun, October 7, 2012Sat, October 6, 2012Fri, October 5, 2012Thu, October 4, 2012Wed, October 3, 2012Tue, October 2, 2012Mon, October 1, 2012Aethlon Medical to Present at the RedChip 15th Annual Small-Cap Conference on October 11th
Published in Health and Fitness on Tuesday, October 9th 2012 at 7:00 GMT by Market Wire
Aethlon Medical to Present at the RedChip 15th Annual Small-Cap Conference on... -- SAN DIEGO, Oct. 9, 2012 /PRNewswire/ --
Aethlon Medical to Present at the RedChip 15th Annual Small-Cap Conference on October 11th
]
SAN DIEGO, Oct. 9, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), announced that Chairman and CEO Jim Joyce will present at the RedChip 15th Annual Fall Small-Cap Conference this Thursday, October 11, 2012 at the Palace Hotel in San Francisco. A live webcast of the presentation will begin at 2:15 p.m. Pacific time (5:15 p.m. Eastern time) and can be accessed online at:
[ http://redchip.com/visibility/conferencePages/SanFran2012/conferenceMain.asp?page=preregister ]
The webcast and archived replay of the company's presentation will be available approximately one week following the presentation at [ www.redchip.com/conference ].
(Photo: [ http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b ])
About Aethlon Medical, Inc.
The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to target HER2+ breast cancer, and a medical device being developed under a contract with DARPA that would reduce the incidence of sepsis in combat-injured soldiers and civilians. For more information, please visit [ www.aethlonmedical.com ].
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
[ jj@aethlonmedical.com ]
Jim Frakes
Chief Financial Officer
858.459.7800 x300
[ jfrakes@aethlonmedical.com ]
Marc Robins
877.276.2467
[ mr@aethlonmedical.com ]
SOURCE Aethlon Medical, Inc.
[ Back to top ]
RELATED LINKS
[ http://www.aethlonmedical.com ]
